| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 2847 |
| 1 | SPIRONOLACTONE | 1912 |
| 2 | BEVACIZUMAB | 1562 |
| 3 | ACETAMINOPHEN | 1423 |
| 4 | RIBAVIRIN | 1181 |
| 5 | PAIN RELIEVER | 1125 |
| 6 | ACETAMINOPHEN 500MG | 1124 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1124 |
| 8 | OMEPRAZOLE MAGNESIUM | 1124 |
| 9 | ASPIRIN | 1092 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESCHERICHIA COLI | 211 | 0.5262 |
| 1 | AMMONIUM CHLORIDE | 94 | 0.3760 |
| 2 | HUMAN RABIES VIRUS IMMUNE GLOBULIN | 24 | 0.3750 |
| 3 | SODIUM CITRATE | 236 | 0.1879 |
| 4 | DEXTROSE AND SODIUM CHLORIDE | 27 | 0.1617 |
| 5 | POTASSIUM IODIDE | 228 | 0.1528 |
| 6 | NATAMYCIN | 58 | 0.1415 |
| 7 | ASIAN GINSENG | 58 | 0.1374 |
| 8 | SODIUM FERRIC GLUCONATE COMPLEX | 267 | 0.1228 |
| 9 | FOLLITROPIN ALFA | 223 | 0.1090 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3277 |
| 1 | Loop Diuretic [EPC] | 3182 |
| 2 | Kinase Inhibitor [EPC] | 2966 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2620 |
| 4 | Proton Pump Inhibitor [EPC] | 2020 |
| 5 | Aldosterone Antagonist [EPC] | 2014 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 1953 |
| 7 | Platinum-based Drug [EPC] | 1863 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1621 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1618 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Platelet-derived Growth Factor [EPC] | 1 | 1.0000 |
| 1 | Polyene Antimicrobial [EPC] | 58 | 0.1415 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 138 | 0.0905 |
| 3 | Vasopressin Receptor Agonist [EPC] | 25 | 0.0755 |
| 4 | Interleukin-5 Antagonist [EPC] | 39 | 0.0567 |
| 5 | Blood Viscosity Reducer [EPC] | 245 | 0.0564 |
| 6 | Vitamin K [EPC] | 377 | 0.0436 |
| 7 | Gonadotropin [EPC] | 85 | 0.0388 |
| 8 | Osmotic Diuretic [EPC] | 161 | 0.0308 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 181 | 0.0286 |